Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00306254 · ClinicalTrials.gov registry record · Phase 2
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,225
- Enrollment target
NCT00306254 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 1,225 participants.
The verdict
NCT00306254, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,225 participants
- Enrollment target
Study Summary
To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery
Interventions
- DRUG Enoxaparin
- DRUG PD 0348292
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,225 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00306254
The ClinicalTrials.gov registry entry for NCT00306254 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enoxaparin is the first listed.
NCT00306254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00306254 about?
NCT00306254 is a clinical study titled "Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery". To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery
What is the current status of trial NCT00306254?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,225 participants. The study started on 2006-03. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00306254?
The interventions under investigation include: Enoxaparin (DRUG), PD 0348292 (DRUG).
Who is sponsoring clinical trial NCT00306254?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.